After host entry through mucosal surfaces, human immunodeficiency virus-1 (HIV-1) disseminates to lymphoid tissues to establish a generalized infection of the immune system. The mechanisms by which this virus spreads among permissive target cells locally during the early stages of transmission and systemically during subsequent dissemination are not known 1 . In vitro studies suggest that the formation of virological synapses during stable contacts between infected and uninfected T cells greatly increases the efficiency of viral transfer 2 . It is unclear, however, whether T-cell contacts are sufficiently stable in vivo to allow for functional synapse formation under the conditions of perpetual cell motility in epithelial 3 and lymphoid tissues 4 . Here, using multiphoton intravital microscopy, we examine the dynamic behaviour of HIV-infected T cells in the lymph nodes of humanized mice. We find that most productively infected T cells migrate robustly, resulting in their even distribution throughout the lymph node cortex. A subset of infected cells formed multinucleated syncytia through HIV envelope-dependent cell fusion. Both uncoordinated motility of syncytia and adhesion to CD4 1 lymph node cells led to the formation of long membrane tethers, increasing cell lengths to up to ten times that of migrating uninfected T cells. Blocking the egress of migratory T cells from the lymph nodes into efferent lymph vessels, and thus interrupting T-cell recirculation, limited HIV dissemination and strongly reduced plasma viraemia. Thus, we have found that HIV-infected T cells are motile, form syncytia and establish tethering interactions that may facilitate cell-to-cell transmission through virological synapses. Migration of T cells in lymph nodes therefore spreads infection locally, whereas their recirculation through tissues is important for efficient systemic viral spread, suggesting new molecular targets to antagonize HIV infection.
In HIV infection, lymph nodes are important sites of viral replication, in which the high local density of CD4 1 T cells and other target cells may favour cell contact-mediated viral spread. Because infection of BLT (bone marrow/liver/thymus) humanized mice 5 replicates many hallmarks of infection in humans [6] [7] [8] , we used this small animal model ( Supplementary Fig. 1a ) and intravital microscopy to investigate the dynamic behaviour of HIV-infected T cells in the stromal environment of lymph nodes.
We first sought to validate this mouse model for studying the effects of HIV infection on T-cell migration. The presence of both naive and memory human CD4 1 and CD8 1 T cells in secondary lymphoid organs of BLT mice demonstrates their general capacity to home to these sites ( Fig. 1a ). To determine the efficiency of this trafficking 1 The Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. 2 process we infused BLT mice with mixtures of isogenic CD4 1 human T cells and mouse CD4 1 T cells from OT-II T-cell receptor (TCR) transgenic mice. Over the course of 18 h, human T cells were half as efficient as mouse cells at entering peripheral lymph nodes, whereas their accumulation in mesenteric lymph nodes was equivalent ( Fig. 1b) . Thus, the interspecies molecular interactions between selectins, chemokine receptors and integrins on human T cells with their ligands expressed on mouse lymph node high endothelial venules 9 are collectively functional, albeit at a slightly reduced level. After entering lymph nodes, T-cell migration is guided by their sensing of chemokines 10 and interactions with the paracortical fibroblastic reticulum 11 , which is well preserved in BLT mice (Supplementary Fig. 1b ). We compared the migration of human and mouse T cells in BLT lymph nodes by multiphoton intravital microscopy (MP-IVM). Intravenously infused human and mouse cells distributed similarly in the lymph node cortex, were indistinguishable in various aspects of motility ( Fig. 1c -e, Supplementary Fig. 1c -e and Supplementary Video 1), and in this regard each resembled mouse T cells in nonhumanized mouse lymph nodes 4 . We concluded that human T-cell homing to lymph nodes was efficient, and cell migration within the lymph nodes of BLT mice was, using mouse T cells as a reference, normal, allowing us to study the effects of HIV infection on this basic process.
To seed lymph nodes with HIV, we injected the footpad of BLT mice with green fluorescent protein (GFP)-expressing, CCR5-using HIV (hereafter referred to as HIV-GFP), which we derived by replacing the V3 loop region of env in the originally CXCR4-tropic NL4-3-IRES-GFP 12 with that of HIV BaL ( Supplementary Fig. 2a, b ). Subcutaneous infection reliably produced high levels of plasma viraemia ( Fig. 2a ) and systemic infection ( Supplementary Fig. 2c ). However, between two and six days after footpad infection, we detected GFP 1 cells in the ipsilateral popliteal lymph node only, and not in remote lymph nodes, indicating that the infection was initially contained in the primary draining lymph nodes ( Fig. 2b and Supplementary Fig. 2e ). The vast majority of these infected cells were resting (SSC low ), antigen-experienced (CD45RO 1 ) T cells with variable expression of CCR7. By day two, some loss of CD4 cell-surface expression was apparent 13 , but this was much more pronounced at day 6, when cells had also downregulated major histocompatibility complex (MHC)-I ( Supplementary Fig. 2e ).
To investigate the localization of HIV-infected T cells in lymph nodes early after footpad infection, we analysed draining lymph nodes by MP-IVM two days after virus inoculation. At this time, GFP 1 cells were evenly distributed up to several hundred micrometres away from the subcapsular sinus (SCS), indicating that lymph-borne HIV arriving in the lymph node SCS has efficient means of infiltrating the lymph node cortex ( Fig. 2c) . In time-lapse recordings it became apparent that GFP-expressing lymph node cells migrated at average two-dimensional (2D) velocities of ,7 mm min 21 and were thus robustly motile, suggesting that their motility facilitated the local dissemination of HIV infection in lymph nodes ( Fig. 2d-f and Supplementary Video 2). Because most infected T cells in early simian immunodeficiency virus (SIV)-infection of macaques are resting memory T cells 14 , and the majority of infected lymph node cells in our BLT mouse model resembled antigen-experienced T cells ( Fig. 2b) , we compared their motility to that of in vitro-generated, GFPexpressing, central memory-like CD4 1 human T cells (hereafter termed T CM s) that express CD62L and CCR7 and migrate to lymph nodes after adoptive transfer ( Supplementary Fig. 3a -c). Compared with this reference population, the motility of HIV-infected lymph node cells was reduced ( Fig. 2e , f, Supplementary Fig. 3d , e and Supplementary Videos 2 and 3), which may reflect the ability of HIV to interfere with cytoskeletal processes involved in cell migration 15, 16 .
Although most infected lymph node cells resembled antigenexperienced T cells in terms of motility, size and shape, a subpopulation (10-20%) of cells stood out by their unusually elongated, thin and sometimes branched trailing edges. These cells reached average skeletal lengths of at times more than 100 mm, whereas T CM s rarely exceeded 20 mm (Fig. 2g, h and Supplementary Videos 2-4). When we tracked skeletal lengths in individual cells along with their motility, we noted that some of the elongated cells continued to be motile ( Fig. 2i ). Similar results were obtained with SF162R3 (ref. 17 ), a GFP-expressing strain of HIV derived from the primary R5-tropic clone SF162 (Supplementary Fig. 4 and Supplementary Video 5). 
RESEARCH LETTER
Because it was possible that our flow cytometry analysis failed to detect these elongated cells (Fig. 2b) , and that these were in fact not T cells, we wanted to determine unambiguously whether HIV-infected T cells could acquire such unusual morphological characteristics in vivo. Therefore, we adopted a co-culture method 18 to efficiently infect T CM s with HIV-GFP in vitro (Fig. 3a) , and transferred these cells into the footpads of BLT mice, from where they migrated to draining popliteal lymph nodes. Recipient BLT mice were pre-treated with a cocktail of antiviral drugs 6 to prevent infection of any host cells. Under these conditions, in which the T-cell identity of GFP 1 cells in popliteal lymph nodes was known, we observed the same overall reduction in motility as well as a sub-population of abnormally elongated cells at a similar frequency to after in situ infection (Fig. 3b-d and Supplementary Video 6). Co-injection of uninfected T CM s also confirmed that these and HIV-infected T cells localized to the same regions of the lymph node and that decreased motility of HIV-infected cells did not result from their sequestration into a particular microenvironment ( Supplementary Fig. 5 and Supplementary Video 6).
The elongated morphology could result from the infection of a T-cell population that has an intrinsic propensity to adopt such shapes. Alternatively, HIV proteins might actively induce this phenotype. To distinguish between these two possibilities, we generated a CCR5using, HIV-derived lentiviral vector that expresses GFP but no HIV proteins in infected cells ( Fig. 3e ). Two days after footpad injection, a similar number of GFP 1 cells was observed in draining lymph nodes as after infection with HIV-GFP. However, these cells did not exhibit elongated shapes. They also migrated faster than HIV-GFP-infected lymph node cells and at similar speeds to T CM s (Fig. 3f-h and Supplementary Video 7) , further supporting the idea that HIV induces migratory deceleration of infected cells. Thus, one or several HIV proteins induces the abnormal shape and decreased motility of HIVinfected T cells.
During HIV assembly, which in migrating, polarized T cells takes place at the uropod 19 , the HIV Env glycoprotein is exposed on the cell surface and can trigger the formation of intercellular adhesive contacts with CD4-expressing cells in vitro [20] [21] [22] [23] . In the lymph node environment, in which T cells are highly motile, such adhesive interactions could lead to abnormal uropod elongation through tethering of infected T cells to uninfected CD4 1 lymph node cells. Supporting this model, we consistently observed stationary behaviour of the trailing edges of migrating T cells, often followed by their rapid retraction, perhaps reflecting sudden release of tethered uropods (Supplementary Video 8). Alternatively, cellular elongations could also result from the formation of multinucleated syncytia, which also depends on the function of Env 24 . To test whether either uropod tethering or syncytia formation are involved in the elongation of HIV-infected T cells, we generated HIV-GFP(DEnv), in which large parts of Env, including the CD4-binding region, are not expressed ( Supplementary Fig. 6a ). When trans-complemented with an exogenous R5 HIV envelope, the virus was as infectious as HIV-GFP, but no secondary infections occurred, as expected, because infected cells expressed no functional Env protein ( Supplementary Fig. 6b-d) . Notably, the elongated phenotype of infected lymph node cells was completely lost in the absence of functional Env (Fig. 4a-c and Supplementary Video 9). However, cells infected with HIV-GFP(DEnv) still migrated at reduced speeds (Fig. 4b, c ), suggesting that HIV factors other than Env were largely responsible for the decreased T-cell motility. Cell elongation did not result from artificial interactions of Env with mouse adhesion or extracellular matrix proteins, as it was not observed in HIV-infected T CM s migrating in the lymph nodes of non-humanized mice ( Fig. 4d and Supplementary Fig. 7 ). To test whether Env interactions with CD4 specifically, or with other human ligands such as the a 4 b 7 -integrin 25 , are involved in tethering, we mutated HIV-GFP to exchange a single crucial amino acid in Env (D368R in the HBX2 consensus sequence) to abrogate CD4-binding 26 (Supplementary Fig. 8 ). Cells infected with HIV-GFP(D368R) showed the same loss of cell elongation as observed after Env deletion (Fig. 4d) .
To examine whether some of the highly elongated T cells are part of multinucleated syncytia, we analysed infected BLT lymph nodes by histology. However, although we did find GFP-expressing cells with several nuclei (not shown), we were unable to visualize the elaborate tethers observed by MP-IVM in thick tissue sections, which may explain in part why these presumably highly labile structures have not been observed in human histological tissue samples. Therefore, we generated HIV-nGFP, in which GFP is targeted to cell nuclei through the addition of a nuclear localization signal ( Supplementary  Fig. 9 ). When we infected BLT mice with this strain, we observed by MP-IVM that the vast majority of elongated lymph node cells were multinucleated syncytia that, given the involvement of Env, probably developed through cell fusion (Fig. 4e, f) . These syncytia frequently migrated with their tightly clustered nuclei moving in a coordinated fashion, but intermittently dispersed so that individual nuclei moved in different directions, yet remained connected by long membrane tethers (Supplementary Video 10). However, both fused and unfused cells also 
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formed free-ending tethers, indicating that those were caused by adhesive interactions with non-visualized CD4 1 cells (Supplementary Video 11). Although similar membrane tethers, such as nanotubes, can also form between T cells in vitro in the absence of viral infection 27 , Env proteins of retroviruses such as HIV have been shown to facilitate their formation 23, 28 . Adhesive tethers may promote cell-to-cell viral transfer through virological synapses, or may reflect the initiation of cell fusion, or both. Movement of free HIV virions within and between tissues is probably restricted by the limits of diffusion, by anatomical barriers, and by soluble immune factors, such as complement and natural antibody 2 . Allowing infected T cells to retain robust motility and to serve as migratory vehicles might therefore be a viral strategy for efficient local and systemic dissemination. If long-range transport of HIV to distant tissues does rely on the trafficking of infected cells during physiological T-cell recirculation, then interfering with lymphocyte trafficking should limit systemic viral dissemination and reduce plasma viraemia.
To block T-cell egress from lymph nodes into efferent lymph vessels, we treated BLT mice with the functional sphingosine 1-phosphate receptor antagonist FTY720 (fingolimod), which resulted in profound lymphopenia ( Supplementary Fig. 10a ). Notably, in mice that received FTY720 at the time of infection with HIV-GFP, viral RNA in peripheral blood remained within or only slightly above the background range (Fig. 4g) , whereas the drug did not show antiviral activity in cell culture ( Supplementary Fig. 10b ). This result was confirmed with another R5-tropic strain, SF162R3 (ref. 17; Fig. 4h ). Two months after infection, viral RNA was strongly reduced, yet not absent from remote lymphoid tissues of treated animals ( Supplementary  Fig. 10c ), suggesting that FTY720 in the longer term did not fully prevent, but only limited dissemination within the lymphoid system. Accordingly, the development of viraemia after FTY720 withdrawal following 8 weeks of treatment indicated that the release of T cells from lymphoid tissues rapidly initiated efficient systemic viral replication (Fig. 4h ). Interestingly, we also observed a reduction in viral load in the draining lymph node in long-term-treated animals ( Supplementary  Fig. 10c ). This may reflect local depletion of HIV T-cell targets, but could also indicate that FTY720 treatment reduces viral replication through a general perturbation of T-cell homeostasis or through delayed, direct antiviral activity, independently of its effect on the trafficking of HIV-infected T cells. However, FTY720 did not affect viraemia in mice with pre-established infection (Fig. 4i) , similar to what was observed in simian-human immunodeficiency virus (SHIV) infection of macaques 29 . Although we cannot rule out other direct or indirect effects of FTY720 on viral replication, the observation that HIV infection is limited and high-level viraemia prevented by interfering with T-cell recirculation before, but not after, systemic viral dissemination, suggests an important role for the trafficking of infected, migratory T cells in the efficient transport of HIV from draining to remote lymphoid tissues.
In summary, we find that HIV induces a partial reduction in the motility of infected T cells, as well as their tethering to and fusion with CD4 1 immune cells in lymph nodes. This may reflect the need for HIV to tune T-cell migratory and interactive behaviour to meet two opposing requirements: the use of motile cells as vehicles to disseminate within and between tissues, which inherently involves short-lived cell contacts; and the formation of virological synapses and, possibly, syncytia, for cell-to-cell spread, which probably requires longer-lasting cell contacts. Reduced motility of infected T cells might favour the formation and maintenance of tethering contacts with potential HIV target cells, while still allowing for efficient trafficking to distant tissues.
METHODS SUMMARY
BLT humanized mice. Sublethally irradiated, female NOD/SCID mice were transplanted under the kidney capsule with 1 mm 3 fragments of human fetal liver and thymus, and injected intravenously with 1 3 10 5 -5 3 10 5 purified CD34 1 human fetal liver cells. After 18-20 weeks, healthy mice with .50% human lymphoid reconstitution in peripheral blood were used for experiments within 6 weeks. In experiments that did not require popliteal lymph nodes, NOD/SCID 3 gc 2/2 (NSG; gc is also known as Il2rg) mice were used as graft recipients. HIV reporter strains. The CCR5-using, GFP-expressing virus NL4-3 IRES-GFP R5 (HIV-GFP) was constructed from pBR-NL4-3-IRES-GFP-nef 1 (ref. 12) by replacing the V3 loop region of env with the corresponding sequence from the R5 clone BaL. HIV-GFP(DEnv) and HIV-GFP(D368R) were generated by site-directed mutagenesis. To produce infectious HIV-GFP(DEnv) and HIV-GFP(D368R), the BaL Env was trans-complemented using a helper plasmid during virus production. HIV-nGFP was generated by inserting the SV40 nuclear localization sequence amino-terminal of GFP in HIV-GFP. The lentiviral vector pHAGE-CMV-GFP was packaged with the R5 Env and standard helper plasmids to produce the CCR5-using 'R5 LV-GFP', which expresses no HIV proteins in infected cells. 
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MP-IVM of HIV-infected cells in lymph nodes. For in situ-infection of lymph node cells, BLT mice were injected into the footpad with 0.5 3 10 5 -1.5 3 10 5 infectious units of recombinant HIV or R5 LV-GFP. Forty-eight hours later, the draining popliteal lymph nodes were imaged by MP-IVM, as described 4 . Alternatively, HIV-GFP-infected T CM s were injected into the footpads of BLT mice pretreated with antiretroviral drugs, and imaged by MP-IVM 12 h later.
METHODS
BLT humanized mice. Female NOD/SCID (NS) and NOD/SCID 3 gc 2/2 (NSG; gc is also known as Il2rg) mice were purchased from Jackson Laboratories and reconstituted at age 6-8 weeks with human immune systems as previously described 30 . In brief, mice were conditioned with sublethal (2 Gy) whole-body irradiation and transplanted with 1 mm 3 fragments of human fetal thymus and liver (17) (18) (19) weeks of gestational age, from Advanced Bioscience Resources) under the kidney capsule. CD34 1 cells were isolated from human fetal liver using anti-CD34 microbeads (Miltenyi Biotec) and injected intravenously (1 3 10 5 -5 3 10 5 cells per mouse) within 6 h of surgery to create BLT mice. Mice were monitored for human haematopoietic reconstitution at 14 and 18 weeks after transplantation. High lymphoid reconstitution in peripheral blood (.25% lymphocytes in PBL, .50% human lymphocytes, .40% T cells among lymphocytes) correlated with optimal lymph node reconstitution suitable for intravital imaging (typically at 18-20 weeks). NS mice were used for all experiments involving footpad injection of HIV or cells and analysis (for example, by MP-IVM) of draining popliteal lymph nodes. NSG mice, which lack popliteal but possess cervical lymph nodes, were used for long-term experiments involving FTY720 treatment. OT-II TCR transgenic mice were obtained from Jackson Laboratories and bred in house.
All experiments were performed in accordance with the rules and regulations of the Center of Comparative Medicine and approved by the MGH Institutional Animal Care and Use Committee and the Harvard Medical Area Standing Committee on Animals. Plasmids and virus production. The proviral plasmid pBR-NL43-IRES-EGFPnef 1 (pIeG-nef 1 ) 31 was obtained from the NIH AIDS Research & Reference Reagent Program (ARRRP). The V3 loop of env was modified to resemble that of HIV BaL and confer R5-tropism, as previously described 32 . In brief, a commercial kit (Stratagene) and primers 59-CCCAACAACAATACAAGAAAAAGTATAC ATATAGGACCAGGCAGAGCATTATATACAACAGGAGAAATAATAGGA GATATAAGACAAGCACATTGTAACATTAG-39 and 59-CTAATGTTACAA TGTGCTTGTCTTATATCTCCTATTATTTCTCCTGTTGTATATAATGCTC TGCCTGGTCCTATATGTATACTTTTTCTTGTATTGTTGTTGGG-39 were used according to the manufacturer's protocol to mutagenize pIeG-nef 1 and obtain pIeG-nef 1 R5. The non-GFP-expressing parental plasmid, pNL4-3, was similarly mutagenized to obtain pNL4-3 R5. Infectious virus generated form pIeG-nef 1 R5 and pNL4-3 R5 are here termed HIV-GFP and HIV, respectively.
The pSVIIIexE7-ADA env-expressing vector (from J. Sodroski) was modified by restriction cloning to express env from pIeG-nef 1 R5 using KpnI and BamHI restriction sites to obtain pSVIIIexE7-BaL.
To construct an env-deleted reporter construct, pIeG-nef 1 R5 was digested with PsiI (nucleotide 6865 and 7599) and religated. The resulting frameshift mutation introduced a premature stop codon while the RRE remained intact. The new plasmid pIeG-nef 1 Denv was packaged with pSVIIIexE7-BaL to obtain HIV-GFP(DEnv).
To construct the CD4-binding-deficient reporter virus HIV-GFP(D368R), site-directed mutagenesis of pIeG-nef 1 R5 was performed using primers 59-GCAATCCTCAGGAGGGCGCCCAGAAATTGTAACG-39 and 59-CGTTA CAATTTCTGGGCGCCCTCCTGAGGATTGC-39 (Stratagene). Successful mutagenesis was confirmed by DNA sequencing. HIV-GFP(D368R) was packaged with pSVIIIexE7-BaL to obtain single-round infectious viral supernatant.
The lentiviral vector construct pHAGE-CMV-GFP is a modification of a construct originally developed in the laboratory of R. C. Mulligan 33 . pHAGE-CMV-GFP was packaged with standard helper plasmids and pSVIIIexE7-BaL to obtain the non-replicating, R5-using vector R5 LV-GFP. To construct the vector pHAGE-NLS-Cerulean, first GFP was replaced in pHAGE-CMV-GFP with Cerulean using restriction enzyme sites NcoI and XmaI to obtain pHAGE-CMV-Cerulean. Then, the complementary primers 59-AGCCCCATGGCT CCAAAAAAGAAGAGAAAGGTAGGCGCCATGGCT-39 and 59-AGCCATG GCGCCTACCTTTCTCTTCTTTTTTGGAGCCATGGGCT-39 were annealed, digested with NcoI and inserted into pHAGE-CMV-Cerulean, placing the nuclear localization signal (NLS) peptide of SV40 immediately upstream of GFP. The same cloning strategy was used to construct HIV-nGFP from HIV-GFP. pSF162R3 was provided by A. Brown.
All HIV and lentiviral stocks were produced by transfecting HEK293T cells using Lipofectamine 2000 (Invitrogen). Viral supernatants were clarified through a 0.22 mm filter and centrifuged at 90,000g for 2 h using an SW28Ti rotor (Beckman Coulter) over a 20% sucrose cushion. Viral stocks were titrated using MAGI.CCR5 cells and expressed as blue focus units per ml, as described previously 34 . Cells. Human and mouse CD4 1 T cells were purified from uninfected BLT and OT-II mice, respectively, by negative immunomagnetic selection (Miltenyl Biotec), and labelled with 2 mM Celltracker green (CMFDA) or 10 mM Celltracker blue (CMAC, both from Invitrogen) before adoptive transfer into BLT mice (see below).
Human CD4 1 central memory-like T cells (T CM s) were generated as described previously with slight modifications 35 . In brief, CD4 1 T cells were isolated from spleen and lymph nodes of BLT mice by positive immunomagnetic selection using CD4 microbeads (Miltenyi Biotec) to purities consistently above 95%. Cells were activated by adding Dynabeads coated with anti-human CD3e/CD28 antibody (3:1 bead:cell ratio, Invitrogen) for 2 days in RPMI 1640 supplemented with 10% FCS (Atlanta Biologicals), 2 mM L-glutamine (Gibco), 1 mM sodium pyruvate and 10 mM HEPES (Mediatech). After 2 days, cells were washed and cultured for another 6-8 days in medium containing 50 IU ml 21 human rIL-2 (R&D Systems), keeping cell density close to 5 3 10 5 cells ml 21 . Cells were used for all experiments between days 8 and 10.
To infect T CM s with HIV-GFP with high efficiency, we used a modified co-culture method 36 . In brief, 23 10 6 MAGI.CCR5 cells were transfected with 10 mg of pIeG-nef 1 R5, and 24 h later T cells were added to the confluent layer of virus-producing cells. Two days later, T cells were collected by Ficoll gradient centrifugation and washed three times before injection into BLT mice. Because we could generate only a limiting number of HIV-infected T CM s by this approach, we injected the cells into footpads for initially selective and efficient delivery to draining lymph nodes 37 . After intravenous (i.v.) injection, cells distributed to all secondary lymphoid tissue and accumulated in only smaller numbers in the popliteal lymph node under study. In some studies, HIV-infected T CM s were injected into the footpad of D H LMP2a mice 38 depleted of natural killer cells through daily i.p. injections of 50 ml anti-asialo GM1 antibody (Wako Chemicals) for 2 days.
To generate T CM s that were not infected with HIV-GFP, but expressed GFP for visualization by MP-IVM and comparison with HIV-GFP-infected cells, we transduced human T cells with vesicular stomatitis virus protein G (VSV-G) pseudotyped pHAGE-CMV-GFP on day 2 after activation. In some experiments, uninfected T CM s were stained for 15 min at 37 uC with 10 mM CellTracker Orange (CMTMR, Invitrogen) before footpad or i.v. injection into BLT mice.
MAGI.CCR5, U87.CD4, U87.CD4.CCR5 and U87.CD4.CXCR4 cells were all obtained from the ARRRP. T-cell homing studies. Isogenic human and mouse OT-II CD4 1 T cells were purified, differentially labelled with cell-tracker dyes, and injected i.v. into BLT mice. Eighteen hours later, flow cytometry was used to determine homing ratios based on the relative frequencies of human and mouse T cells injected and recovered in various tissues. HIV infection of BLT mice. For analyses of HIV infection in popliteal lymph nodes, BLT mice were injected into footpads with 5 3 10 4 -1.5 3 10 5 infectious units of various HIV strains.
For longer-term studies on the effects of FTY720 treatment on the course of infection, 4 3 10 4 infectious units of HIV-GFP were injected into the cheek skin of NSG-derived BLT mice, which is drained by cervical lymph nodes. Plasma viraemia. Mice were bled from the superficial temporal vein at indicated times and sera stored at 280 uC. Viral RNA was isolated from 20-70 ml of plasma using the QIAamp viral RNA kit (Qiagen), reverse transcribed, and complementary DNA amplified by quantitative PCR using SYBR green (Qiagen) on the Lightcycler 480-II (Roche). Plasma from uninfected BLT mice was used to determine the reverse transcriptase PCR (RT-PCR) background signal, which was consistently higher than the background signal obtained with water. Quantification of tissue viral load. Mice were euthanized at the specified days and lymph nodes and spleen were removed and stored in 200 ml of RNAlater solution overnight (Ambion). Single-cell suspensions from tissues were obtained using the gentleMACS dissociator (Miltenyi Biotec) and RNA was extracted using a commercial kit (Qiagen). Quantification of viral RNA was performed as described above. Viral loads were normalized to total tissue RNA. Pharmacological treatments. FTY720 (1 mg kg 21 body weight) or vehicle was injected i.p. every other day starting 1 h before HIV infection of BLT mice to block T cell egress from lymph nodes 39 .
FTC (100 mg kg 21 ) and TDF (150 mg kg 21 ) were i.p. injected daily starting 2 days before footpad injection of HIV-infected T CM s to prevent infection of recipient BLT mice. Intravital multiphoton microscopy and image analysis. BLT mice were anaesthetized and the popliteal lymph nodes microsurgically exposed for MP-IVM as previously described 40 . Imaging depth was typically 80-200 mm below the lymph node capsule. For multiphoton excitation and second harmonic generation, a MaiTai Ti:sapphire laser (Newport/Spectra-Physics) was tuned to between 830 and 920 nm for optimized excitation of the fluorescent probes used. For 4D recordings of cell migration, stacks of 11 optical sections (512 3 512 pixels) with 4-mm z-spacing were acquired on an Ultima IV multiphoton microscope (Prairie Technologies) every 15 or 24 s to provide imaging volumes of 40 mm in depth. Emitted light and second harmonic signals were detected through 455/ RESEARCH LETTER
